Analysis of MVP and VPARP promoters indicates a role for chromatin remodeling in the regulation of MVP

Biochimica et Biophysica Acta - Gene Structure and Expression

Volumn 1678, Issue 1, 2004, Pages 33-46

  Emre, Nil ^a   Raval Fernandes, Sujna ^a   Kickhoefer, Valerie A ^a   Rome, Leonard H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Chromatin; HDAC; Histone deacetylase; Major vault protein; MDR; Multi drug resistance; MVP; Telomerase associated protein 1; TEP1; Trichostatin A; TSA; Vault poly(ADP ribose) polymerase; VPARP

Indexed keywords

BUTYRIC ACID; HISTONE DEACETYLASE INHIBITOR; LUNG RESISTANCE PROTEIN; MESSENGER RNA; PROTEIN; RIBOSE; TELOMERASE ASSOCIATED PROTEIN 1; TRICHOSTATIN A; UNCLASSIFIED DRUG; VAULT POLY(ADENOSINE DIPHOSPHATE RIBOSE)POLYMERASE;

ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CHROMATIN STRUCTURE; DRUG SENSITIVITY; DRUG SPECIFICITY; EMBRYO; FEMALE; GENE ACTIVATION; GENE ACTIVITY; GENE AMPLIFICATION; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; HUMAN; HUMAN CELL; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; TATA BOX; UPREGULATION;

ANIMALS; BASE SEQUENCE; BUTYRATES; CARRIER PROTEINS; CHROMATIN ASSEMBLY AND DISASSEMBLY; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; HUMANS; MICE; MOLECULAR SEQUENCE DATA; POLY(ADP-RIBOSE) POLYMERASES; PROMOTER REGIONS (GENETICS); TUMOR CELLS, CULTURED; UP-REGULATION; VAULT RIBONUCLEOPROTEIN PARTICLES;

MURINAE;

EID: 1842453281     PISSN: 01674781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbaexp.2004.01.005     Document Type: Article

References (47)

1. Suprenant K.A. Vault ribonucleoprotein particles: sarcophagi, gondolas, or safety deposit boxes? Biochemistry. 41:2002;14447-14454.
2. Kedersha N.L., Rome L.H. Isolation and characterization of a novel ribonucleoprotein particle: large structures contain a single species of small RNA. J. Cell Biol. 103:1986;699-709.
3. Stephen A.G., Raval-Fernandes S., Huynh T., Torres M., Kickhoefer V.A., Rome L.H. Assembly of vault-like particles in insect cells expressing only the major vault protein. J. Biol. Chem. 276:2001;23217-23220.
4. Hamill D.R., Suprenant K.A. Characterization of the sea urchin major vault protein: a possible role for vault ribonucleoprotein particles in nucleocytoplasmic transport. Dev. Biol. 190:1997;117-128.
5. Herrmann C., Zimmermann H., Volknandt W. Analysis of a cDNA encoding the major vault protein from the electric ray Discopyge ommata. Gene. 188:1997;85-90.
6. Kedersha N.L., Miquel M.C., Bittner D., Rome L.H. Vaults: II. Ribonucleoprotein structures are highly conserved among higher and lower eukaryotes. J. Cell Biol. 110:1990;895-901.
7. Kickhoefer V.A., Siva A.C., Kedersha N.L., Inman E.M., Ruland C., Streuli M., Rome L.H. The 193-kD vault protein, VPARP, is a novel poly(ADP-ribose) polymerase. J. Cell Biol. 146:1999;917-928.
8. Harrington L., McPhail T., Mar V., Zhou W., Oulton R., Bass M.B., Arruda I., Robinson M.O. A mammalian telomerase-associated protein. Science. 275:1997;973-977.
9. Kickhoefer V.A., Stephen A.G., Harrington L., Robinson M.O., Rome L.H. Vaults and telomerase share a common subunit, TEP1. J. Biol. Chem. 274:1999;32712-32717.
10. Liu Y., Snow B.E., Hande M.P., Baerlocher G., Kickhoefer V.A., Yeung D., Wakeham A., Itie A., Siderovski D.P., Lansdorp P.M., Robinson M.O., Harrington L. Telomerase-associated protein TEP1 is not essential for telomerase activity or telomere length maintenance in vivo. Mol. Cell. Biol. 20:2000;8178-8184.
11. Kickhoefer V.A., Searles R.P., Kedersha N.L., Garber M.E., Johnson D.L., Rome L.H. Vault ribonucleoprotein particles from rat and bullfrog contain a related small RNA that is transcribed by RNA polymerase III. J. Biol. Chem. 268:1993;7868-7873.
12. Kickhoefer V.A., Rajavel K.S., Scheffer G.L., Dalton W.S., Scheper R.J., Rome L.H. Vaults are up-regulated in multidrug-resistant cancer cell lines. J. Biol. Chem. 273:1998;8971-8974.
13. van Zon A., Mossink M.H., Schoester M., Scheffer G.L., Scheper R.J., Sonneveld P., Wiemer E.A. Multiple human vault RNAs. Expression and association with the vault complex. J. Biol. Chem. 276:2001;37715-37721.
14. Kickhoefer V.A., Emre N., Stephen A.G., Poderycki M.J., Rome L.H. Identification of conserved vault RNA expression elements and a non-expressed mouse vault RNA gene. Gene. 309:2003;65-70.
15. Chugani D.C., Rome L.H., Kedersha N.L. Evidence that vault ribonucleoprotein particles localize to the nuclear pore complex. J. Cell Sci. 106:1993;23-29.
16. Kong L.B., Siva A.C., Rome L.H., Stewart P.L. Structure of the vault, a ubiquitous cellular component. Structure Fold Des. 7:1999;371-379.
17. Scheffer G.L., Schroeijers A.B., Izquierdo M.A., Wiemer E.A., Scheper R.J. Lung resistance-related protein/major vault protein and vaults in multidrug-resistant cancer. Curr. Opin. Oncol. 12:2000;550-556.
18. Mossink M.H., van Zon A., Franzel-Luiten E., Schoester M., Kickhoefer V.A., Scheffer G.L., Scheper R.J., Sonneveld P., Wiemer E.A. Disruption of the murine major vault protein (MVP/LRP) gene does not induce hypersensitivity to cytostatics. Cancer Res. 62:2002;7298-7304.
19. Schroeijers A.B., Siva A.C., Scheffer G.L., de Jong M.C., Bolick S.C., Dukers D.F., Slootstra J.W., Meloen R.H., Wiemer E., Kickhoefer V.A., Rome L.H., Scheper R.J. The Mr 193,000 vault protein is up-regulated in multidrug-resistant cancer cell lines. Cancer Res. 60:2000;1104-1110.
20. Siva A.C., Raval-Fernandes S., Stephen A.G., LaFemina M.J., Scheper R.J., Kickhoefer V.A., Rome L.H. Up-regulation of vaults may be necessary but not sufficient for multidrug resistance. Int. J. Cancer. 92:2001;195-202.
21. Hu Y., Stephen A.G., Cao J., Tanzer L.R., Slapak C.A., Harrison S.D., Devanarayan V., Dantzig A.H., Starling J.J., Rome L.H., Moore R.E. A very early induction of major vault protein accompanied by increased drug resistance in U-937 cells. Int. J. Cancer. 97:2002;149-156.
22. Lange C., Walther W., Schwabe H., Stein U. Cloning and initial analysis of the human multidrug resistance-related MVP/LRP gene promoter. Biochem. Biophys. Res. Commun. 278:2000;125-133.
23. Mossink M., van Zon A., Franzel-Luiten E., Schoester M., Scheffer G., Scheper R., Sonneveld P., Wiemer E. The genomic sequence of the murine major vault protein and its promoter. Gene. 294:2002;225.
24. Kickhoefer V.A., Liu Y., Kong L.B., Snow B.E., Stewart P.L., Harrington L., Rome L.H. The Telomerase/vault-associated protein TEP1 is required for vault RNA stability and its association with the vault particle. J. Cell Biol. 152:2001;157-164.
25. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
26. Ogretmen B., Safa A.R. Negative regulation of MDR1 promoter activity in MCF-7, but not in multidrug resistant MCF-7/Adr, cells by cross-coupled NF-kappa B/p65 and c-Fos transcription factors and their interaction with the CAAT region. Biochemistry. 38:1999;2189-2199.
27. Fort P., Marty L., Piechaczyk M., el Sabrouty S., Dani C., Jeanteur P., Blanchard J.M. Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate-dehydrogenase multigenic family. Nucleic Acids Res. 13:1985;1431-1442.
28. Suske G. The Sp-family of transcription factors. Gene. 238:1999;291-300.
29. Moustakas A., Souchelnytskyi S., Heldin C.H. Smad regulation in TGF-beta signal transduction. J. Cell Sci. 114:2001;4359-4369.
30. Kitazono M., Sumizawa T., Takebayashi Y., Chen Z.S., Furukawa T., Nagayama S., Tani A., Takao S., Aikou T., Akiyama S. Multidrug resistance and the lung resistance-related protein in human colon carcinoma SW-620 cells. J. Natl. Cancer Inst. 91:1999;1647-1653.
31. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods. 65:1983;55-63.
32. Jin S., Scotto K.W. Transcriptional regulation of the MDR1 gene by histone acetyltransferase and deacetylase is mediated by NF-Y. Mol. Cell. Biol. 18:1998;4377-4384.
33. Borst P., Evers R., Kool M., Wijnholds J. A family of drug transporters: the multidrug resistance-associated proteins. J. Natl. Cancer Inst. 92:2000;1295-1302.
34. Labialle S., Gayet L., Marthinet E., Rigal D., Baggetto L.G. Transcriptional regulators of the human multidrug resistance 1 gene: recent views. Biochem. Pharmacol. 64:2002;943-948.
35. Scheffer G.L., Wijngaard P.L., Flens M.J., Izquierdo M.A., Slovak M.L., Pinedo H.M., Meijer C.J., Clevers H.C., Scheper R.J. The drug resistance-related protein LRP is the human major vault protein. Nat. Med. 1:1995;578-582.
36. Izquierdo M.A., Shoemaker R.H., Flens M.J., Scheffer G.L., Wu L., Prather T.R., Scheper R.J. Overlapping phenotypes of multidrug resistance among panels of human cancer-cell lines. Int. J. Cancer. 65:1996;230-237.
37. Izquierdo M.A., Scheffer G.L., Flens M.J., Giaccone G., Broxterman H.J., Meijer C.J., van der Valk P., Scheper R.J. Broad distribution of the multidrug resistance-related vault lung resistance protein in normal human tissues and tumors. Am. J. Pathol. 148:1996;877-887.
38. Raymond M., Rose E., Housman D.E., Gros P. Physical mapping, amplification, and overexpression of the mouse mdr gene family in multidrug-resistant cells. Mol. Cell. Biol. 10:1990;1642-1651.
39. Slovak M.L., Ho J.P., Cole S.P., Deeley R.G., Greenberger L., de Vries E.G., Broxterman H.J., Scheffer G.L., Scheper R.J. The LRP gene encoding a major vault protein associated with drug resistance maps proximal to MRP on chromosome 16: evidence that chromosome breakage plays a key role in MRP or LRP gene amplification. Cancer Res. 55:1995;4214-4219.
40. Laurencot C.M., Scheffer G.L., Scheper R.J., Shoemaker R.H. Increased LRP mRNA expression is associated with the MDR phenotype in intrinsically resistant human cancer cell lines. Int. J. Cancer. 72:1997;1021-1026.
41. Cornwell M.M., Smith D.E. SP1 activates the MDR1 promoter through one of two distinct G-rich regions that modulate promoter activity. J. Biol. Chem. 268:1993;19505-19511.
42. Rohlff C., Glazer R.I. Regulation of the MDR1 promoter by cyclic AMP-dependent protein kinase and transcription factor Sp1. Int. J. Oncol. 12:1998;383-386.
43. Lania L., Majello B., De Luca P. Transcriptional regulation by the Sp family proteins. Int. J. Biochem. Cell Biol. 29:1997;1313-1323.
44. Ogretmen B., Safa A.R. Identification and characterization of the MDR1 promoter-enhancing factor 1 (MEF1) in the multidrug resistant HL60/VCR human acute myeloid leukemia cell line. Biochemistry. 39:2000;194-204.
45. Levine M., Tjian R. Transcription regulation and animal diversity. Nature. 424:2003;147-151.
46. Choi H.S., Lee J.H., Park J.G., Lee Y.I. Trichostatin A, a histone deacetylase inhibitor, activates the IGFBP-3 promoter by upregulating Sp1 activity in hepatoma cells: alteration of the Sp1/Sp3/HDAC1 multiprotein complex. Biochem. Biophys. Res. Commun. 296:2002;1005-1012.
47. Hou M., Wang X., Popov N., Zhang A., Zhao X., Zhou R., Zetterberg A., Bjorkholm M., Henriksson M., Gruber A., Xu D. The histone deacetylase inhibitor trichostatin A derepresses the telomerase reverse transcriptase (hTERT) gene in human cells. Exp. Cell Res. 274:2002;25-34.